that the risk of transformation is lower than it was before the introduction of rituxumab.Associazione Angela Serra per la Ricerca sul Cancro, European Lymphoma Institute, European Hematology Association Lymphoma Group, Fondazione Italiana Linfomi, Spanish Group of Lymphoma and Bone Marrow Transplantation...
Two HHV8-related illnesses in a HIV-negative patient: Kaposi’s sarcoma and multicentric Castleman’s disease. Response to treatment with rituximab and CHOP. Actas Dermosifiliogr. 2006;97:385–90 (in Spanish with English abstract). Article CAS Google Scholar Cervera Grau JM, Galiana Esquerdo...